ABC Columbia
The chain says their private brand could save diabetic upwards of 75% on the needed medication
Jun 30, 2021 10:21 PM EDT
Image: Bloomberg via Getty Images, FILEBloomberg via Getty Images, FILE
(ABC News) Walmart announced it is launching its own private brand of insulin, which the big box chain says will save customers with diabetes up to 75% on the lifesaving drug.
Walmart’s ReliOn brand will sell private label NovoLog short-acting insulin that is manufactured by the pharmaceutical firm Novo Nordisk.
The analog insulin vials and pens will save customers between 58% to 75% off the cash price of branded insulin products, or up to $101 per vial or $251 per package of “FlexPens,” the retailer said.
Walmart to launch its own line of insulin this week
thedenverchannel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedenverchannel.com Daily Mail and Mail on Sunday newspapers.
Five Walmart clinics approved for Jacksonville | Jax Daily Record | Jacksonville Daily Record
jaxdailyrecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jaxdailyrecord.com Daily Mail and Mail on Sunday newspapers.
Development Today | Jax Daily Record | Jacksonville Daily Record
jaxdailyrecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jaxdailyrecord.com Daily Mail and Mail on Sunday newspapers.
Walmart s new private brand of insulin could save uninsured patients up to 75%
dallasnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dallasnews.com Daily Mail and Mail on Sunday newspapers.